No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

Nigeria faces a household energy crisis. Approximately 127 million people and more than 24 million families cook inefficiently with open fires. Only one in... Wars and extreme weather conditions have ...

Howdy! Festival of the Arts is in full swing with a new Paint By Numbers mural, new pins were released, Living with the Land updates, and so much more fun in Disney’s Animal Kingdom and EPCOT. Good ...

National Coordinator, the Nigeria Reduced Emissions from Deforestation and Degradation (REDD ) Programme, Salisu Dahiru, has called on state governments in Nigeria to embrace... The African Union ...

DnD 2024 backgrounds grant characters stat increases, a starting feat, a range of proficiencies, and a clear backstory. This is a major shake-up to the original Dungeons and Dragons 5e rules, and it ...

Now, a little more than a year later, she’s making cuts of her own. The neuro-focused biotech is “making changes” to its research team to “reinvigorate the company's drug discovery ...

After reading a question asking the Patriots to consider joining the social media app, Kirsch provided background information ... the league gives us the green light we’ll get back on ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

In a 2023 Healthline survey, 79% of those who reported being interested in trying CBD said they were specifically interested in CBD gummies. And while older adults are interested in CBD as a pain ...

In 2019, Stan­ford Uni­ver­si­ty pro­fes­sor Irv Weiss­man and a col­league pub­lished a pa­per that rep­re­sent­ed a new way to tar­get some ag­gres­sive can­cers.